商务合作
动脉网APP
可切换为仅中文
Financing includes a $17 million senior credit facility from BOK Financial and $8 million in equity from existing investors and global single-family offices.
融资包括来自BOK Financial的1700万美元优先信贷额度,以及来自现有投资者和全球单一家族办公室的800万美元股权资金。
SAN FRANCISCO
旧金山
,
,
July 28, 2026
2026年7月28日
/PRNewswire/ -- Excedr, Inc. ('Excedr' or the 'Company'), a leading provider of full-service laboratory equipment leasing solutions for the life sciences and healthcare industries, today announced the closing of $25 million in growth capital. The round includes a $17 million senior credit facility from BOK Financial and $8 million in equity from existing investors and a group of global single-family offices with extensive experience in biopharma, lab services, and specialty finance..
/美通社/ -- Excedr, Inc.(简称“Excedr”或“公司”)是生命科学和医疗保健行业领先的全方位实验室设备租赁解决方案提供商,今日宣布完成2500万美元的增长资本融资。本轮融资包括来自BOK Financial的1700万美元高级信贷额度,以及现有投资者和一组在生物制药、实验室服务和专业金融领域拥有丰富经验的全球单一家族办公室提供的800万美元股权投资。
The new credit facility, provided by BOK Financial, consists of a revolving line of credit and term loan structured to support the continued expansion of Excedr's equipment leasing portfolio. The BOK facility and additional equity position Excedr to capitalize on increasing demand for flexible, non-dilutive financing solutions across the life sciences ecosystem..
由BOK Financial提供的新信贷额度包括循环信用额度和定期贷款,旨在支持Excedr设备租赁组合的持续扩张。BOK的信贷额度以及额外的股权融资使Excedr能够把握生命科学生态系统中对灵活、非稀释性融资解决方案日益增长的需求。
Excedr has established itself as a trusted partner to both emerging biotech companies and established industry players, supported by long-standing relationships with leading OEMs such as Danaher, Sartorius, Bio-Rad, and others. The Company's distinctive approach combines scientific expertise, flexible financing, and full-service equipment support, enabling customers to access mission-critical equipment while preserving their capital, reducing downtime, and accelerating research productivity..
Excedr 已与新兴生物技术公司和成熟行业企业建立了值得信赖的合作伙伴关系,这得益于其与丹纳赫(Danaher)、赛多利斯(Sartorius)、伯乐(Bio-Rad)等领先原始设备制造商(OEM)长期建立的合作关系。该公司独特的方法将科学专业知识、灵活的融资方案和全面的设备支持相结合,使客户能够在保留资本、减少停机时间并加速研究生产力的同时,获取对任务至关重要的设备。
'We are excited to partner with Excedr to support its next phase of growth,' said Reed Upson, Senior Vice President, Asset-Based Lending at BOK Financial. 'Excedr has built a highly differentiated platform, serving a diverse and high-quality customer base across the life sciences industry. Their strong OEM relationships, disciplined underwriting approach, and track record of performance position the Company well for continued expansion.'.
“我们很高兴与Excedr合作,支持其下一阶段的成长。”BOK Financial资产担保贷款高级副总裁Reed Upson表示。“Excedr打造了一个高度差异化的平台,为生命科学行业中多样化且高质量的客户群体提供服务。其强大的原始设备制造商(OEM)合作关系、严谨的承保方法以及良好的业绩记录,为公司持续扩张奠定了坚实基础。”
'Securing this growth capital marks an important milestone for Excedr,' said Jon Chee, Cofounder and Chief Executive Officer of Excedr. 'BOK Financial's flexible credit solution, together with the support of our existing and new investors, enables us to expand our equipment portfolio, deepen our OEM partnerships, and further invest in our platform so that more scientists can access missioncritical equipment without tying up equity or working capital.
Excedr 联合创始人兼首席执行官 Jon Chee 表示:“获得这笔增长资本标志着 Excedr 的一个重要里程碑。BOK Financial 的灵活信贷解决方案,加上我们现有及新投资者的支持,使我们能够扩大设备组合,深化与原始设备制造商(OEM)的合作伙伴关系,并进一步投资于我们的平台,从而让更多科学家无需占用股权或营运资金即可获得对任务至关重要的设备。”
This in turn helps improve patient outcomes across the life sciences and healthcare ecosystem.'.
这反过来又有助于改善整个生命科学和医疗保健生态系统的患者预后。
The transaction comes at an inflection point for the life sciences industry, as organizations across the R&D spectrum seek flexible, non-dilutive solutions that allow them to do more science with less capital.
此次交易正值生命科学行业的拐点,研发领域的各类机构纷纷寻求灵活且非稀释性的解决方案,以期以更少的资本投入开展更多的科学研究。
About BOK Financial
关于 BOK Financial
For more than a century, BOK Financial has been a financial services partner for consumers, businesses and wealth clients alike. It brings the financial insight and resources you'd expect from a national institution — but delivers it with the care, clarity, and consistency of a neighbor who knows your name and understands your goals..
一个多世纪以来,BOK Financial 一直是消费者、企业和财富客户信赖的金融服务合作伙伴。它具备全国性金融机构所应有的金融洞察力和资源,同时以邻里的关怀、清晰和一致性为您服务——就像一位熟知您姓名并理解您目标的邻居。
Its Asset-Based Lending group specializes in structuring flexible credit facilities of $5 million to $50 million, supported by accounts receivable, inventory, and equipment, helping companies finance working capital, growth initiatives, and strategic investments. With deep experience across a range of industries, BOK Financial partners with management teams and sponsors to deliver customized financing solutions that support long-term growth..
其资产支持贷款团队专注于构建500万至5,000万美元的灵活信贷额度,以应收账款、存货和设备作为担保,帮助企业为营运资金、增长举措和战略投资提供融资。凭借在多个行业的深厚经验,BOK Financial与管理团队及投资方携手合作,提供定制化的融资解决方案,助力长期增长。
About Excedr, Inc.
关于 Excedr, Inc.
Founded in 2011 and incubated within University of California, Berkeley laboratories, Excedr is a scientific equipment leasing company that provides operating lease solutions and ongoing support for mission-critical laboratory instrumentation across therapeutics, diagnostics, contract research organizations, and other life sciences segments.
Excedr 成立于2011年,孵化于加州大学伯克利分校的实验室,是一家科学设备租赁公司,为治疗、诊断、合同研究组织以及其他生命科学领域的关键任务实验室仪器提供经营租赁解决方案和持续支持。
Excedr's non-dilutive capital platform enables scientists and organizations to access cutting-edge technology from the manufacturers of their choice while preserving capital, extending runway, and accelerating R&D and commercialization..
Excedr 的非稀释性资本平台使科学家和机构能够从他们选择的制造商那里获取尖端技术,同时保留资金、延长运营时间并加速研发和商业化进程。
Nick McAfee
尼克·麦卡菲
Marketing Manager, Excedr
Excedr 营销经理
[email protected]
[email protected]
SOURCE Excedr
来源 Excedr
21
二十一
%
百分之
more press release views with
更多新闻稿浏览量,借助
Request a Demo
申请演示